{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:19:38Z","timestamp":1787552378002,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pyruvate kinase deficiency (PKD) is a rare autosomal recessive inherited hemolytic anemia caused by pathogenic variants in the PKLR gene. The disease exhibits marked clinical heterogeneity, ranging from compensated anemia to severe transfusion-dependent phenotypes presenting early in childhood. Although supportive care and emerging pharmacologic agents such as pyruvate kinase activators have improved disease management, treatment options remain limited for patients with severe, transfusion-dependent disease. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents a potential curative approach. However, clinical experience in pediatric PKD remains limited, and reported outcomes are heterogeneous. In particular, data regarding standardized conditioning strategies, donor variability, and early post-transplant outcomes are still insufficient. Here, we report a single-center case series of six pediatric patients with genetically confirmed PKD who underwent allo-HSCT between 2019 and 2026. The cohort included both matched sibling and unrelated donors with varying HLA compatibility. All patients achieved successful hematopoietic engraftment, with neutrophil and platelet recovery occurring within 12\u201316 days post-transplantation. Complete donor chimerism (&amp;gt;98%) was achieved in all evaluable patients by day +21. No primary graft failure was observed, and no severe acute or chronic graft-versus-host disease occurred during early follow-up. Importantly, patients demonstrated rapid correction of transfusion dependence following transplantation. However, follow-up duration was heterogeneous, ranging from several months to over six years, and long-term outcomes remain under continued observation. This study provides a homogeneous real-world experience suggesting that allo-HSCT using a thiotepa- and ATG-containing myeloablative regimen is feasible in selected pediatric PKD patients, including those receiving unrelated donor grafts. These findings support further investigation of standardized transplant approaches and early intervention strategies in severe pediatric PKD. Larger multicenter studies with long-term follow-up are required to validate safety, durability, and late effects of transplantation in this rare disease.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1831203","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:36Z","timestamp":1787549496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Successful hematopoietic stem cell transplantation in pediatric pyruvate kinase deficiency: a single-center Asian case series demonstrating favorable outcomes"],"prefix":"10.3389","volume":"17","author":[{"given":"Haomin","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v19.3.267.267","article-title":"Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia","volume":"127","author":"Tanaka","year":"1962","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejm196405142702001","article-title":"Extreme hemolysis and red-cell distortion in erythrocyte pyruvate kinase deficiency","volume":"270","author":"Oski","year":"1964","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.02.005","article-title":"Updates and advances in pyruvate kinase deficiency","volume":"29","author":"Luke","year":"2023","journal-title":"Trends Mol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-810796","article-title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","volume":"131","author":"Grace","year":"2018","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11469","article-title":"Genotype\u2010phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency","volume":"95","author":"Bianchi","year":"2020","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2015.12.009","article-title":"Red blood cell PK deficiency: An update of PK-LR gene mutation database","volume":"57","author":"Canu","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v83.8.2311.2311","article-title":"Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish","volume":"83","author":"Kanno","year":"1994","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2116634","article-title":"Mitapivat versus placebo for pyruvate kinase deficiency","volume":"386","author":"Al-Samkari","year":"2022","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27312","article-title":"Clinically meaningful improvements in patient\u2010reported outcomes in mitapivat\u2010treated patients with pyruvate kinase deficiency","volume":"99","author":"Kuo","year":"2024","journal-title":"Am J Hematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2021.08.005","article-title":"Consensus document for the diagnosis and treatment of pyruvate kinase deficiency","volume":"157","author":"Morado","year":"2021","journal-title":"Med Cl\u00ednica (English Edition)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.240846","article-title":"The variable manifestations of disease in pyruvate kinase deficiency and their management","volume":"105","author":"Al-Samkari","year":"2020","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2020.8305","article-title":"Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusion-dependent pyruvate kinase deficiency anemia","volume":"12","author":"Shimomura","year":"2020","journal-title":"Hematol Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2431231","article-title":"Ovarian tissue cryopreservation for a girl with combined severe hemolytic anemia due to pyruvate kinase deficiency: a case report and literature review","volume":"40","author":"Jiang","year":"2024","journal-title":"Gynecological Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v95.11.3585.011k39_3585_3588","article-title":"Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population","volume":"95","author":"Beutler","year":"2000","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v96.12.4005","article-title":"Prevalence of pyruvate kinase deficiency in a northern European population in the north of England","volume":"96","author":"Carey","year":"2000","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19601","article-title":"Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry","volume":"205","author":"Glenth\u00f8j","year":"2024","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(23)00377-0","article-title":"Diagnosis and management of pyruvate kinase deficiency: international expert guidelines","volume":"11","author":"Al-Samkari","year":"2024","journal-title":"Lancet Haematol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.161166","article-title":"Recommendations regarding splenectomy in hereditary hemolytic anemias","volume":"102","author":"Iolascon","year":"2017","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2141.1978.tb07127.x","article-title":"Erythrocyte populations in pyruvate kinase deficiency anaemia following splenectomy","volume":"39","author":"Leblond","year":"1978","journal-title":"Br J Haematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-170948","article-title":"Lentiviral-mediated gene therapy for adults and children with severe pyruvate kinase deficiency: Results from an ongoing global phase 1 study","volume":"140","author":"Shah","year":"2022","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.87","article-title":"Safe and efficient gene therapy for pyruvate kinase deficiency","volume":"24","author":"Garcia-Gomez","year":"2016","journal-title":"Mol Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01961-x","article-title":"Mitapivat: A review in pyruvate kinase deficiency in adults","volume":"83","author":"Zhuang-Yan","year":"2023","journal-title":"Drugs"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1902678","article-title":"Safety and efficacy of mitapivat in pyruvate kinase deficiency","volume":"381","author":"Grace","year":"2019","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14078","article-title":"A pyruvate kinase deficiency child with novel PK\u2010LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation","volume":"25","author":"Zhan","year":"2021","journal-title":"Pediatr Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.218","article-title":"Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy","volume":"51","author":"Kim","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702576","article-title":"Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency","volume":"26","author":"Tanphaichitr","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.177857","article-title":"Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency","volume":"103","author":"van Straaten","year":"2018","journal-title":"Haematologica"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29148","article-title":"Pyruvate kinase deficiency in children","volume":"68","author":"Chonat","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31440","article-title":"Mitapivat for acquired pyruvate kinase deficiency","volume":"72","author":"Al\u2010Samkari","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/6503311","article-title":"Pyruvate kinase deficiency causing priapism","volume":"2023","author":"Shankar","year":"2023","journal-title":"Case Rep Hematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30322","article-title":"Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders","volume":"70","author":"Fraser","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10238-026-02105-7","article-title":"Superior outcomes with the FABT regimen in haploidentical transplantation for aplastic anemia in patients under 40 years old: a single-center retrospective study","volume":"26","author":"Tan","year":"2026","journal-title":"Clin Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18483","article-title":"Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine\u2013busulfan\u2013cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial","volume":"200","author":"Zhang","year":"2023","journal-title":"Br J Haematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000393","article-title":"Modern management of Fanconi anemia","volume":"2022","author":"Dufour","year":"2022","journal-title":"Hematology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2024.01725","article-title":"Impact of hematopoietic stem cell transplantation on growth outcomes in mucopolysaccharidosis: a systematic review","volume":"68","author":"Abbasi","year":"2025","journal-title":"Clin Exp Pediatr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1831203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:31:38Z","timestamp":1787549498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1831203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1831203"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1831203","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1831203"}}